Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$54.7M Buy
1,983,060
+874,187
+79% +$19.3M ﹤0.01% 1723
2026
Q1
$16.2M Sell
1,108,873
-237,581
-18% -$3.49M ﹤0.01% 2642
2025
Q4
$17M Buy
1,346,454
+362,094
+37% +$5.34M ﹤0.01% 2541
2025
Q3
$15.1M Sell
984,360
-126,565
-11% -$2.04M ﹤0.01% 2542
2025
Q2
$17.5M Buy
1,110,925
+315,936
+40% +$4.79M ﹤0.01% 2248
2025
Q1
$15.2M Sell
794,989
-163,259
-17% -$3.57M ﹤0.01% 2293
2024
Q4
$22.8M Sell
958,248
-108,819
-10% -$3.04M ﹤0.01% 2002
2024
Q3
$29.9M Buy
1,067,067
+340,855
+47% +$9.63M ﹤0.01% 1690
2024
Q2
$19M Buy
726,212
+113,939
+19% +$2.37M ﹤0.01% 1930
2024
Q1
$13.4M Buy
612,273
+7,572
+1% +$162K ﹤0.01% 2198
2023
Q4
$14.1M Sell
604,701
-169,696
-22% -$3.41M ﹤0.01% 2217
2023
Q3
$15.3M Buy
774,397
+382,795
+98% +$7.54M ﹤0.01% 2021
2023
Q2
$8.88M Buy
391,602
+185,755
+90% +$3.74M ﹤0.01% 2560
2023
Q1
$4.04M Sell
205,847
-572,016
-74% -$11M ﹤0.01% 3245
2022
Q4
$13.4M Buy
+777,863
New +$13.8M ﹤0.01% 2314

Other funds holding RXO

Goldman Sachs's RXO Position: Q2 2026 in Review

Goldman Sachs increased its RXO (RXO) stake by 79% in Q2 2026, buying an estimated $19.3M and bringing the position to 1,983,060 shares worth $54.7M. The position accounts for ﹤0.01% of the portfolio, ranked #1723.

Goldman Sachs first reported a position in RXO in Q4 2022 and has held it in 15 quarters since. 303 funds tracked by Wall St. Rank hold RXO as of Q2 2026.

  • Goldman Sachs held 1,983,060 shares of RXO worth $54.7M as of Q2 2026.
  • Goldman Sachs bought 874,187 RXO shares in Q2 2026, an estimated $19.3M.
  • RXO made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #1723 holding.
  • Goldman Sachs first reported a position in RXO in Q4 2022 and has held it in 15 quarters since.
  • 303 funds tracked by Wall St. Rank held RXO as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.